CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Breast Cancer

Oncology NEWS International. Vol. 19 No. 5
Focus on Breast Cancer 

State breast cancer screening programs struggle financially

By KATHLYN STONE | May 17, 2010

There's no shortage of controversy when it comes to mammography-based breast cancer screening. Most recently, investigators at the Cochrane Centre in Copenhagen published yet another analysis of screening programs and declared that there was no evidence that screening saves lives.

Mammography screening advocates were quick to point out flaws in the Nordic research, just as they were quick to criticize the U.S. Preventive Task Force last year when it recommended raising the beginning screening age from 40 to 50 (British Medical Journal online, March 24, 2010, and March 30, 2010).

But this debate may be academic if women don't have access to any screening services at all: The prolonged U.S. recession has put mammogram and other cancer screening programs at risk for closure. Rhode Island's free screening program ran out of money in early 2010, forcing it to discontinue offering services until federal funding for the program is replenished in July. California eliminated its no-cost "Every Woman Counts" mammograms to low-income women under age 50 in 2010 and placed a six-month freeze on new enrollments. The screening program run by the state of New York also saw its funding shrink in 2009 because of $3.5 million in cuts to the state's budget.

“The prolonged U.S. recession has put mammogram and other cancer screening programs at risk for closure.”
— Donald A. Berry, PhD

Compounding the problem is that more women, because of job losses, loss of healthcare insurance, or other financial hardships, are now eligible for free screening. One of the factors in the temporary closure of the Rhode Island program was that the state was faced with a 50% rise in demand for screenings that it could not support.

There is no national database to compile information on the states that have reduced or eliminated breast cancer screening programs, but cuts are definitely taking place from coast to coast.

While lack of finances is the main reason for closure, free screening programs are also looking at scientific evidence and expert guidelines to help them determine if screening programs are worthwhile.

"Most states are looking at new evidence, especially that having to do with mammograms," said Joseph Bailes, MD, chair of the ASCO government relations committee.

But "whether states implement the U.S. Preventive Task Force's guidelines remains up in the air." he said.

Minnesota: A case study

The Sage Screening Program in Minnesota is a perfect example of a program that is experiencing major ups and downs because of tough economic times. Free screenings barely survived state budget cuts and severe midyear "unallotments" made by the governor to some Minnesota Department of Health (MDH) programs.

The Sage Screening Program covers the cost of mammograms and cervical cancer screenings that are free to uninsured women or those who have copays through their private insurer. Sage is funded by the CDC's National Breast and Cervical Cancer Early Detection Program, the Susan G. Komen Foundation, and other charitable organizations as well as the state.

Sage follows the American Cancer Society (ACS) guidelines that call for annual mammograms for women 40 and over and for younger women with symptoms or special health risks, including a family history of breast cancer. Sage also receives in-kind support from the ACS.

According to Jonathan Slater, PhD, chief of the MDH Cancer Control Section, 137 cases of breast cancer were detected among the more than 18,200 Minnesota women screened through the Sage program in 2009. Thus about 1 in every 138 screening mammograms resulted in a diagnosis of cancer.

David Arons, government relations director for the ACS in Minnesota, was among the advocates who helped shield Sage from larger state budget cuts. He said MDH Commissioner Sanne Magnan, MD, also deserved kudos. "She stood up for [Sage] last year during the budget process," he said.

'Short-sighted' thinking

Cutting screening to save money is very "short-sighted" thinking, Dr. Bailes said. "Diagnosing a tumor early is a lot less costly to the healthcare system compared with treating someone with an advanced disease," he noted. In 2007, the CDC's National Breast and Cervical Cancer Early Detection Program was reauthorized through fiscal year 2011. The program provides Pap tests and other screenings for qualified women aged 18 to 64 and mammograms for qualified women aged 40 to 64. To qualify, women must be uninsured and have annual incomes lower than 250% of the federal poverty level.

It remains to be seen what effect the healthcare reform law will have on breast cancer screening. The law will not be fully implemented until 2014, but some provisions, such as the elimination of private plan copays for screening tests, take effect sooner. How the law is implemented will also impact screening availability.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Sherri Tenpenny | May 31, 2010 3:20 PM EDT

Diagnosing a tumor is less costly? how about diagnosing a concern and address it before it turns into a tumor? Breast thermography has been doing that for >30 years. Time for conventional medicine to look at those studies and do a better job with true PREVENTION, not just "find it early" methods.

by Barbara Brusatori | July 28, 2010 1:34 PM EDT

There needs to be more follow up when there are abnormalities in the mamograms.  I had a breast biopsy on my left breast which turned out to be stage III invasive ductal carcinoma triple negative breast cancer .  In my right breast there are several microcalcifications  but more of them.  I also had abnormal mamograms  in my left breast   ever since 1992 when I had my first surigal breast biopsy.  So why don't they do more follow up on these abnormalities?






 
RELATED CONTENT

50 Shades of Pink—And Why It Helps to Know the Difference
May 17, 2013
It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
ONCOLOGY,  May 13, 2013
HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit From Trastuzumab Maintenance
May 7, 2013
PIK3CA Mutations Negatively Affect Survival in Trastuzumab-Treated HER2-Positive Breast Cancer
May 6, 2013
US Task Force Recommends Breast Cancer Medications for High-Risk Women
April 24, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Breast Cancer
Evidence on Breast Cancer
Guidelines on Breast Cancer
Patient Education on Breast Cancer
Clinical Trials on Breast Cancer
Practical Articles on Breast Cancer
Research and Reviews on Breast Cancer
All "Breast Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy